{
  "report_rows": [
    {
      "kpi": "Ongoing Operations Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.60B vs. cons $1.54B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "East Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$0.59B vs. cons $0.55B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Retail Adjusted EBITDA",
      "prediction": "MISS",
      "answer": "pred ~$0.68B vs. cons $0.72B",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "2026 Ongoing Operations Adjusted EBITDA guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$7.20B vs. cons $7.20B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "2026 Ongoing Operations Adjusted FCF before Growth guidance midpoint",
      "prediction": "UNCHANGED",
      "answer": "guide ~$4.33B vs. cons $4.33B (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "2027 Ongoing Operations Adjusted EBITDA midpoint opportunity",
      "prediction": "UNCHANGED",
      "answer": "guide ~$7.60B vs. cons $7.60B (FY2027)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 2.5,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.0,
  "day5_path": "FADE",
  "day5_rationale": "A ~$1.60B EBITDA result versus ~$1.54B consensus supports an initial positive reaction, but unchanged FY2026 EBITDA guidance of ~$7.20B versus ~$7.20B consensus and unchanged FY2027 opportunity of ~$7.60B versus ~$7.60B leave little out-period estimate-upside catalyst.",
  "day5_confidence": "MEDIUM"
}